US Patent 11866507 Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same
Patent 11866507 was granted and assigned to Inhibrx on January, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11866507 Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.